Showing results (1-10 of 379) with videos related to

Sort By:
Pageof 38
Expert Review of Anticancer Therapy|August 3, 2011
Human papillomavirus testing and genotyping in cervical screeningMatejka Rebolj, Elsebeth Lynge, Jesper Bonde
BMJ (Clinical Research Ed.)|May 25, 2011
Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic reviewMatejka Rebolj, Jesper Bonde, Sisse Helle Njor, et al.
Gynecologic Oncology|December 3, 2014
Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytologyMatejka Rebolj, Elsebeth Lynge, Ditte Ejegod, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2015
A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30yearsMatejka Rebolj, Jesper Bonde, Ditte Ejegod, et al.
Journal of Clinical Microbiology|August 19, 2016
Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial AssaysMatejka Rebolj, Jesper Bonde, Sarah Preisler, et al.
Plos One|January 21, 2016
Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and AboveMatejka Rebolj, Jesper Bonde, Sarah Preisler, et al.
Nature Reviews. Clinical Oncology|November 11, 2009
Primary HPV screening for cervical cancer prevention: results from European trialsElsebeth Lynge, Matejka Rebolj
BMC Cancer|July 22, 2016
Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample studySarah Preisler, Matejka Rebolj, Ditte Møller Ejegod, et al.
Pageof 38